Clinical Trial Update: Erlotinib for Hepatocellular Carcinoma Chemoprevention [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating erlotinib for chemoprevention of hepatocellular carcinoma in patients with cirrhosis or advanced liver fibrosis. The trial sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Cirrhosis
• Liver Fibrosis

Drugs mentioned

• Tarceva (erlotinib)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Cirrhosis, Liver, Advanced Liver Fibrosis | Phase 2 | Status: NOT_YET_RECRUITING